Biomanufacturing Shakes Off Challenges and Remains a Vital Target Industry
Within the larger pharmaceutical sector, the number of U.S. biomanufacturing plants, where so many of the country’s newest medicines and other therapies are produced for clinical trials and commercial sale, has grown by more than 50 percent in recent years, according to Pharmaceutical Research and Manufacturers (PhRMA), a leading industry association. more....